The Employees' State Insurance Corporation (ESIC) on August 07, 2023, notified the rate revision under DG ESIC Rate Contract.
The following amendment has been stated:
• For Ifosfamide inj-Each Vial to contain: Ifosfamide 1gm FOSFA, the amended reduced price Rs. 315.00 per Vial + GST extra.
The amended price will be effective from April 01, 2023.
[Notification No. U-25/12/149-153/Amendment/Price Revision/2023-Medv/347]